ADAMTS13 and ischemic stroke: In the experimental study of Zhao and colleagues, it was shown that infusion of recombinant human ADAMTS13 before reperfusion in mice with ischemic stroke resulted in a significantly reduced infarct volume and was associated with improved functional outcomes [22].